Medicover Genetics enables the implementation of genetics in routine healthcare through an integrated model of specialised clinical services and laboratory solutions. With more than 27 years of clinical genetics experience, the company supports healthcare systems, laboratories, and clinicians worldwide through innovative and translational genetic solutions across oncology, reproductive health, rare diseases, and precision medicine. Operating through CAP, CLIA and ISO 15189 accredited laboratories, Medicover Genetics delivers clinically validated solutions that focus on caring for patients at every stage of their clinical pathway. www.medicover-genetics.com

Medicover Genetics is part of Medicover, an international healthcare and diagnostic services company listed on Nasdaq Stockholm. www.medicover.com